U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06992154) titled 'Role of Akkermansia Muciniphila in Acne Vulgaris' on May 19.
Brief Summary: The project explores the use of Pendulum's Glucose Control, which contains a unique combination of probiotics, including Akkermansia muciniphila, Clostridium beijerinckii, Anaerobutyricum hallii, Clostridium butyricum, and Bifidobacterium infantis, to treat acne by improving gut health and reducing inflammation. These probiotic strains work synergistically to enhance the gut's protective barrier, lower harmful substances such as lipopolysaccharides, and increase the production of beneficial compounds like short-chain fatty acids, which can help modulate immun...